Literature DB >> 28029248

Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release.

Monika Szlezak1, Dorota Nieciecka1, Aleksandra Joniec1, Marek Pękała1, Ewa Gorecka1, Mélanie Emo2, Marie J Stébé2, Paweł Krysiński1, Renata Bilewicz1.   

Abstract

Hybrid materials consisting of a monoolein lipidic cubic phase (LCP) incorporating two types of magnetic nanoparticles (NP) were designed as addressable drug delivery systems. The materials, prepared in the form of a gel, were subsequently used as a macroscopic layer modifying an electrode and, after dispersion to nanoscale, as magnetocubosomes. These two LCPs were characterized by small-angle X-ray scattering (SAXS), cross-polarized microscopy, magnetic measurements, and phase diagrams. The magnetic dopants were hydrophobic NPoleic and hydrophilic NPcitric, characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM), and their influence on the properties of the cubic phases was investigated. The removal of the anticancer drug, Doxorubicin (Dox) from the hybrid cubic phase gels was studied by electrochemical methods. The advantages of incorporating magnetic nanoparticles into the self-assembled lipid liquid crystalline phases include the ability to address the cubic phase nanoparticle containing large amounts of drug and to control the kinetics of the drug release.

Entities:  

Keywords:  doxorubicin; lipidic cubic phase; liquid crystalline phase; magnetic nanoparticles; magnetocubosome

Mesh:

Substances:

Year:  2017        PMID: 28029248     DOI: 10.1021/acsami.6b12889

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

Review 1.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

2.  Super-swelled lyotropic single crystals.

Authors:  Hojun Kim; Ziyuan Song; Cecilia Leal
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

3.  A magnetically responsive nanocomposite scaffold combined with Schwann cells promotes sciatic nerve regeneration upon exposure to magnetic field.

Authors:  Zhongyang Liu; Shu Zhu; Liang Liu; Jun Ge; Liangliang Huang; Zhen Sun; Wen Zeng; Jinghui Huang; Zhuojing Luo
Journal:  Int J Nanomedicine       Date:  2017-10-24

4.  Synchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs.

Authors:  Paola Astolfi; Michela Pisani; Elisabetta Giorgini; Barbara Rossi; Alessandro Damin; Francesco Vita; Oriano Francescangeli; Lorenzo Luciani; Rossana Galassi
Journal:  Nanomaterials (Basel)       Date:  2020-09-16       Impact factor: 5.076

Review 5.  Electromagnetically Stimuli-Responsive Nanoparticles-Based Systems for Biomedical Applications: Recent Advances and Future Perspectives.

Authors:  Raffaele Longo; Giuliana Gorrasi; Liberata Guadagno
Journal:  Nanomaterials (Basel)       Date:  2021-03-26       Impact factor: 5.076

6.  Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb3+ Ions.

Authors:  Dorota Nieciecka; Aleksandra Rękorajska; Dariusz Cichy; Paulina Końska; Michał Żuk; Paweł Krysiński
Journal:  Nanomaterials (Basel)       Date:  2022-02-26       Impact factor: 5.076

7.  AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.

Authors:  Dorota K Flak; Vivian Adamski; Grzegorz Nowaczyk; Kosma Szutkowski; Michael Synowitz; Stefan Jurga; Janka Held-Feindt
Journal:  Int J Nanomedicine       Date:  2020-10-05

8.  Hybrid Theranostic Cubosomes for Efficient NIR-Induced Photodynamic Therapy.

Authors:  Urszula Bazylińska; Dominika Wawrzyńczyk; Julita Kulbacka; Giacomo Picci; Livia Salvati Manni; Stephan Handschin; Marco Fornasier; Claudia Caltagirone; Raffaele Mezzenga; Sergio Murgia
Journal:  ACS Nano       Date:  2022-03-25       Impact factor: 18.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.